Combretastatin A-4 vascular damage to tumours.
O'Brien
C
C
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D008870:Microtubules / Q000187:drug effects; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D008517:Phytotherapy; D010944:Plants / Q000737:chemistry; D011485:Protein Binding; D013267:Stilbenes / Q000494:pharmacology / Q000627:therapeutic use*; D014404:Tubulin / Q000378:metabolism
D000972:Antineoplastic Agents, Phytogenic; D013267:Stilbenes; D014404:Tubulin; C058728:fosbretabulin